Teletherapy for deaf kids: a new way to bridge language gaps?

NCT ID NCT04928209

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether speech-language teletherapy can improve language outcomes in deaf or hard-of-hearing children aged 0-27 months. Researchers enrolled 210 children, some publicly insured and some privately insured, and gave some access to an 18-month teletherapy program. The goal was to see if teletherapy could help address language disparities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
speech-language teletherapy
What this could lead to
If it works, this could provide a way to improve speech and language development in deaf or hard-of-hearing children, especially those with limited access to in-person therapy.
What could go wrong
This is a completed study, but results may not apply to all children or settings. Teletherapy may not be as effective as in-person care for some families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lucile Packard Children's Hospital Stanford

    Palo Alto, California, 94303, United States

  • Rady Children's Hospital - San Diego

    San Diego, California, 92123, United States

  • Seattle Children's Hospital

    Seattle, Washington, 98145, United States

  • The University of California - San Francisco

    San Francisco, California, 94158, United States

  • UCSF Benioff Children's Hospital - Oakland

    Oakland, California, 94609, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.